Huntingtin and Its Role in Mechanisms of RNA-Mediated Toxicity

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG-repeat expansion in the Huntingtin (HTT) gene.
• While the Huntingtin protein has been extensively studied, recent evidence points to the role of the mutant HTT RNA transcript in HD pathogenesis.
• Cellular dysfunction in HD is not solely due to protein toxicity but also involves RNA-mediated mechanisms.

Purpose of the Study:

• To review recent studies on RNA-mediated molecular mechanisms contributing to cellular dysfunction in Huntington's disease models.
• To summarize novel therapeutic strategies targeting the mutant HTT transcript for HD treatment.

Main Methods:

• Literature review of recent studies on RNA-mediated mechanisms in HD.
• Analysis of research on mis-splicing, aberrant translation, miRNA deregulation, RNA transport, and mitochondrial RNA regulation in HD models.
• Summary of emerging RNA-targeting therapeutic approaches.

Main Results:

• Mutant HTT RNA transcripts contribute to cellular dysfunction through various mechanisms including mis-splicing and aberrant translation.
• Deregulation of microRNA (miRNA) machinery, RNA transport, and mitochondrial RNA also play roles in HD pathogenesis.
• Several RNA-targeting strategies are under investigation for therapeutic potential.

Conclusions:

• RNA-mediated mechanisms are critical contributors to cellular dysfunction in Huntington's disease.
• Targeting the mutant HTT transcript offers promising therapeutic avenues for HD, potentially halting disease progression.
• Current palliative treatments for HD may be complemented by novel RNA-targeting strategies.